Significantly Elevated C-Reactive Protein Levels after Epicardial Clipping of the Left Atrial Appendage

Abstract

Objective

Besides mechanical and anatomical changes of the left atrium, epicardial closure of the left atrial appendage has also possible homeostatic effects. The aim of this study was to assess whether epicardial clipping of the left atrial appendage has different biochemical effects compared with complete removal of the left atrial appendage.

Methods

Eighty-two patients were included and underwent a totally thoracoscopic AF ablation procedure. As part of the procedure, the left atrial appendage was excluded with an epicardial clip (n = 57) or the left atrial appendage was fully amputated with an endoscopic vascular stapler (n = 25). From all patients’ preprocedural and postprocedural blood pressure, electrolytes and inflammatory parameters were collected.

Results

The mean age and left atrial volume index were comparable between the epicardial clip and stapler group (64 ± 8 years vs. 60 ± 9 years, P = non-significant; 44 ±15 mL/m² vs. 40 ± 13 mL/m², P = nonsignificant). Patients receiving left atrial appendage clipping had significantly elevated C-reactive protein levels compared with patients who had left atrial appendage stapling at the second, third, and fourth postoperative day (225 ± 84 mg/L vs. 149 ± 76 mg/L, P = 0.002, 244 ± 78 vs. 167 ± 76, P = 0.004, 190 ± 74vs. 105 ± 48, P < 0.001, respectively). Patients had a significant decrease in sodium levels, systolic, and diastolic blood pressure at 24 and 72 hours after left atrial appendage closure. However, this was comparable for both the left atrial appendage clipping and stapling group.

Conclusions

Increased activation of the inflammatory response was observed after left atrial appendage clipping compared with left atrial appendage stapling. Furthermore, a significant decrease in blood pressure was observed after surgical removal of the left atrial appendage. Whether the inflammatory response affects the outcome of arrhythmia surgery needs to be further evaluated.

Keywords

Left atrial appendage Minimally invasive surgery Epicardial clip Thoracoscopic procedure Atrial fibrillation Surgical ablation

Get full access to this article

View all access options for this article.

References

Boersma

L.V.

, Ince

, Kische

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017; 14: 1302–1308.

Kirchhof

, Benussi

, Kotecha

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016; 18: 1609–1678.

Emmert

M.Y.

, Puippe

, Baumuller

Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg. 2014; 45: 126–131.

Kurfirst

, Mokracek

, Canadyova

, Frana

, Zeman

Epicardial clip occlusion of the left atrial appendage during cardiac surgery provides optimal surgical results and long-term stability. Interact Cardiovasc Thorac Surg. 2017; 1; 25: 37–40.

Yoshihara

, Nishikimi

, Kosakai

Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. J Thorac Cardiovasc Surg. 1998; 116: 213–219.

Nakamura

, Niinuma

, Chiba

Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Am J Cardiol. 1997; 79: 966–970.

Maybrook

, Pillarisetti

, Yarlagadda

Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device. J Interv Card Electrophysiol. 2015; 43: 245–251.

Perk

, De Backer

, Gohlke

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635–1701.

van Laar

, Geuzebroek

G.S.

, Hofman

F.N.

, Van Putte

B.P.

The totally thoracoscopic left atrial maze procedure for the treatment of atrial fibrillation. Multimed Man Cardiothorac Surg. 2016. Available at: http://mmcts.org/tutorial/99. Accessed February 2018.

10.

Ailawadi

, Gerdisch

M.W.

, Harvey

R.L.

Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011; 142: 1002–1009.

11.

Suwalski

, Witkowska

, Drobinski

Stand-alone totally thoracoscopic left atrial appendage exclusion using a novel clipping system in patients with high risk of stroke - initial experience and literature review. Kardiochir Torakochirurgia Pol. 2015; 12: 298–303.

12.

Min

J.J.

, Nam

, Kim

T.K.

Relationship between early postoperative C-reactive protein elevation and long-term postoperative major adverse cardiovascular and cerebral events in patients undergoing off-pump coronary artery bypass graft surgery: a retrospective study. Br J Anaesth. 2014; 113: 391–401.

13.

Galea

, Cardillo

M.T.

, Caroli

Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Tex Heart Inst J. 2014; 41: 461–468.

14.

Engelmann

M.D.

, Svendsen

J.H.

Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005; 26: 2083–2092.

15.

Marott

S.C.

, Nordestgaard

B.G.

, Zacho

Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol. 2010; 56: 789–795.

16.

Chang

S.N.

, Tsai

C.T.

, Wu

C.K.

A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation. J Intern Med. 2012; 272: 305–315.

17.

Bruins

, te Velthuis

, Yazdanbakhsh

A.P.

Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997; 96: 3542–3548.

18.

Tselentakis

E.V.

, Woodford

, Chandy

, Gaudette

G.R.

, Saltman

A.E.

Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res. 2006; 135: 68–75.

19.

Cesari

, Penninx

B.W.

, Newman

A.B.

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003; 108: 2317–2322.

20.

Conway

D.S.

, Buggins

, Hughes

, Lip

G.Y.

Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol. 2004; 43: 2075–2082.

21.

Conway

D.S.

, Buggins

, Hughes

, Lip

G.Y.

Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol. 2004; 93: 1368–1373.

22.

Ross

Atherosclerosis—an inflammatory disease. N Engl J Med. 1999; 340: 115–126.

23.

Fichtlscherer

, Rosenberger

, Walter

D.H.

, Breuer

, Dimmeler

, Zeiher

A.M.

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000; 102: 1000–1006.

24.

Venugopal

S.K.

, Devaraj

, Yuhanna

, Shaul

, Jialal

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002; 106: 1439–1441.

25.

Torzewski

, Rist

, Mortensen

R.F.

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000; 20: 2094–2099.

26.

Danenberg

H.D.

, Kantak

, Grad

, Swaminathan

R.V.

, Lotan

, Edelman

E.R.

C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol. 2007; 78: 246–252.